Category

Biochips Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type (DNA, Protein, Lab-on, Others), By Application (Drug Discovery And Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, Others), By End-User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes, Others) And By Geography - Forecasts From 2019 To 2024

Published: May 2021 | Report Code:  KSI061612937 | Pages:  121

The global biochips market was valued at US$8.155 billion in 2018 and is expected to grow at a CAGR of 19.7% over the forecast period to reach a total market size of US$23.982 billion by 2024. A biochip is a set of diminished microarrays that are placed on a strong substrate that allows many experiments to be executed at the same time to obtain output in less time.

It contains millions of sensor elements or biosensors and unlike microchips, is not an electronic device. Biochip acts like a microreactor that can detect particular analyte like enzyme, protein, DNA, biological molecule or antibody. Its main functions are to perform hundreds of biological reactions in a few seconds, tracking humans/animals, restoring records, and in as BP sensors, glucose detector, and an oxygen sensor in the medical field. Biochips Market has garnered a substantial share due to the rise in prevalence of life-threatening disorders, a surge in the number of aged people who are susceptible to cancer, increase in its applications, and high demand for personalized medicines. Additionally, the growth in the healthcare expenditure across the globe, increased government funding and R&D investment in biotechnology by the key players are also supporting the growth of the market. However, high prices, lack of knowledge among the consumers, and a threat to individual privacy are acting as restraints in the growth of the market.

The “Biochips Market – Forecasts from 2019 to 2024” is an exhaustive study of this niche technology market which aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, application, end-user, and geography.

The biochips market has been segmented based on type, application, end-user, and geography. Based on type the market has been segmented into DNA Chip, Protein Chip, Lab-on-Chip, and others. By application, the market has been classified into Drug Discovery and Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, and Others. By end-user, the market has been classified as Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes, and Others.

Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and the Asia Pacific regions. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.

Major players in the biochips market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the biochips market.

Global Biochips Market Scope:

Report Metric Details
 Market size value in 2018  US$8.155 billion
 Market size value in 2024  US$23.982 billion
 Growth Rate  CAGR of 19.7% from 2018 to 2024
 Base year  2018
 Forecast period  2019–2024
 Forecast Unit (Value)  USD Billion
 Segments covered  Type, Application, End-User, And Geography
 Regions covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies covered Abbott Laboratories, Perkin Elmer Corporation, Fluidigm Corporation, BioMerieux S.A, Horiba Ltd., Randox Laboratories, Thermo Fisher Scientific, Bio-Rad Laboratories, Illumina Inc., Agilent Technologies
 Customization scope  Free report customization with purchase

Segmentation:

  • By Type
    • DNA Chip
    • Protein Chip
    • Lab-on-Chip
    • Others
  • By Application
    • Drug Discovery and Development
    • Disease Diagnostics
    • Genomics
    • Proteomics
    • Agriculture
    • Others
  • By End-User
    • Biotechnology & Pharmaceutical Companies
    • Hospitals & Diagnostics Centers
    • Academic & Research Institutes
    • Others
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • United Kingdom
      • Others
    • Middle East and Africa
      • Israel
      • South Africa
      • Others
    • Asia Pacific
      • China
      • Japan
      • South Korea
      • India
      • Others

Frequently Asked Questions (FAQs)

Q1. What will be the biochips market size by 2024?
A1. The global biochips market is expected to reach a market size of US$23.982 billion in 2024.
 
Q2. What is the size of global biochips market?
A2. Biochips market was valued at US$8.155 billion in 2018.
 
Q3. What are the growth prospects for biochips market?
A3. The biochips market is expected to grow at a CAGR of 19.7% over the forecast period.
 
Q4. How is the global biochips market segmented?
A4. The biochips market has been segmented based on type, application, end-user, and geography. 
 
Q5. What factors are anticipated to drive the biochips market growth?
A5. Biochips Market has garnered a substantial share due to the rise in prevalence of life-threatening disorders, a surge in the number of aged people who are susceptible to cancer, an increase in its applications, and high demand for personalized medicines.

Explore custom options available with this study:

  • Request customization

  • Buy sections of the study

  • Buy country specific report

  • Request excel, Historical data

  • Subscription inquiry

  • Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.

Confidentiality

We are in compliance with the global privacy laws.

OUR CLIENTS